Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gouji Toyokawa

Showing results (1-10 of 168) with videos related to

Pageof 17
Sort By:
Respiratory Investigation|December 3, 2014
Anaplastic lymphoma kinase rearrangement in lung cancer: its biological and clinical significanceGouji Toyokawa, Takashi Seto
Oncology Research and Treatment|June 6, 2015
Updated Evidence on the Mechanisms of Resistance to ALK Inhibitors and Strategies to Overcome Such Resistance: Clinical and Preclinical DataGouji Toyokawa, Takashi Seto
Clinical Lung Cancer|July 3, 2014
ALK inhibitors: what is the best way to treat patients with ALK+ non-small-cell lung cancer?Gouji Toyokawa, Takashi Seto
Clinical Lung Cancer|September 16, 2014
Multimodality treatment with surgery for locally advanced non-small-cell lung cancer with n2 disease: a review articleGouji Toyokawa, Mitsuhiro Takenoyama, Yukito Ichinose
Expert Review of Anticancer Therapy|December 22, 2018
ALK testing methods: is there a winner or loser?Yuka Kozuma, Gouji Toyokawa, Takashi Seto
Clinical Lung Cancer|November 21, 2016
W'ALK' Into the Next StageGouji Toyokawa, Takashi Seto, Mitsuhiro Takenoyama, et al.
Thoracic Cancer|August 7, 2018
Significance of spread through air spaces in early-stage lung adenocarcinomas undergoing limited resectionGouji Toyokawa, Yuichi Yamada, Tetsuzo Tagawa, et al.
Oncotargets and Therapy|September 4, 2018
Spotlight on lorlatinib and its potential in the treatment of NSCLC: the evidence to dateTakaki Akamine, Gouji Toyokawa, Tetsuzo Tagawa, et al.
Cancer Metastasis Reviews|September 7, 2015
Insights into brain metastasis in patients with ALK+ lung cancer: is the brain truly a sanctuary?Gouji Toyokawa, Takashi Seto, Mitsuhiro Takenoyama, et al.
BMJ Case Reports|December 31, 2025
Chronic expanding haematoma caused by rib fractures after radiation therapySodai Nagata, Yue Cong, Gouji Toyokawa, et al.
Pageof 17

Showing results (1-10 of 168) with videos related to

Sort By:
Pageof 17
Respiratory Investigation|December 3, 2014
Anaplastic lymphoma kinase rearrangement in lung cancer: its biological and clinical significanceGouji Toyokawa, Takashi Seto
Oncology Research and Treatment|June 6, 2015
Updated Evidence on the Mechanisms of Resistance to ALK Inhibitors and Strategies to Overcome Such Resistance: Clinical and Preclinical DataGouji Toyokawa, Takashi Seto
Clinical Lung Cancer|July 3, 2014
ALK inhibitors: what is the best way to treat patients with ALK+ non-small-cell lung cancer?Gouji Toyokawa, Takashi Seto
Clinical Lung Cancer|September 16, 2014
Multimodality treatment with surgery for locally advanced non-small-cell lung cancer with n2 disease: a review articleGouji Toyokawa, Mitsuhiro Takenoyama, Yukito Ichinose
Expert Review of Anticancer Therapy|December 22, 2018
ALK testing methods: is there a winner or loser?Yuka Kozuma, Gouji Toyokawa, Takashi Seto
Clinical Lung Cancer|November 21, 2016
W'ALK' Into the Next StageGouji Toyokawa, Takashi Seto, Mitsuhiro Takenoyama, et al.
Thoracic Cancer|August 7, 2018
Significance of spread through air spaces in early-stage lung adenocarcinomas undergoing limited resectionGouji Toyokawa, Yuichi Yamada, Tetsuzo Tagawa, et al.
Oncotargets and Therapy|September 4, 2018
Spotlight on lorlatinib and its potential in the treatment of NSCLC: the evidence to dateTakaki Akamine, Gouji Toyokawa, Tetsuzo Tagawa, et al.
Cancer Metastasis Reviews|September 7, 2015
Insights into brain metastasis in patients with ALK+ lung cancer: is the brain truly a sanctuary?Gouji Toyokawa, Takashi Seto, Mitsuhiro Takenoyama, et al.
BMJ Case Reports|December 31, 2025
Chronic expanding haematoma caused by rib fractures after radiation therapySodai Nagata, Yue Cong, Gouji Toyokawa, et al.
Pageof 17